title: Chronic human parvovirus B19 infection associated with interstitial lung disease.
authors.affiliation: Department of Pediatrics, Bikur Cholim General Hospital, Jerusalem, Israel. aklar@inter.net.il
authors.forename: Aharon
authors.initials: A
authors.lastname: Klar
authors.forename: Ariel
authors.initials: A
authors.lastname: Halamish
authors.forename: David
authors.initials: D
authors.lastname: Shoseyov
authors.forename: Pascal
authors.initials: P
authors.lastname: Cassinotti
authors.forename: Gunter
authors.initials: G
authors.lastname: Siegl
authors.forename: Chaim
authors.initials: C
authors.lastname: Springer
authors.forename: Gila
authors.initials: G
authors.lastname: Shazberg
authors.forename: Haggit
authors.initials: H
authors.lastname: Hurvitz
mesh_terms: D000367:Age Factors; D000914:Antibodies, Viral / Q000032:analysis; D001706:Biopsy; D002178:Candidiasis, Chronic Mucocutaneous / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003241:Consanguinity; D004797:Enzyme-Linked Immunosorbent Assay; D005183:Failure to Thrive / Q000209:etiology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007153:Immunologic Deficiency Syndromes; D007223:Infant; D008168:Lung / Q000473:pathology; D017563:Lung Diseases, Interstitial / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D010322:Parvoviridae Infections / Q000150:complications* / Q000276:immunology; D016732:Parvovirus B19, Human / Q000235:genetics / Q000276:immunology; D016133:Polymerase Chain Reaction; D012010:Red-Cell Aplasia, Pure / Q000209:etiology / Q000628:therapy
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous